Gammagard Liquid and rHuPH20 in PID

Clinical trial NCT00814320 · COMPLETED

Trial details

NCT number: NCT00814320
Sponsor: Baxalta now part of Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency Diseases (PID)

Start date: 2008-12-18
Primary completion: 2010-11-11
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.